학술논문

Evaluating the efficacy of an integrated smoking cessation intervention for mental health patients: study protocol for a randomised controlled trial
Document Type
article
Source
Trials. 15(1)
Subject
Health Services and Systems
Nursing
Public Health
Health Sciences
Substance Misuse
Brain Disorders
Behavioral and Social Science
Tobacco Smoke and Health
Clinical Trials and Supportive Activities
Tobacco
Clinical Research
Prevention
Mental Health
Cardiovascular
Cancer
Mental health
Respiratory
Stroke
Good Health and Well Being
Clinical Protocols
Counseling
Delivery of Health Care
Integrated
Health Behavior
Health Knowledge
Attitudes
Practice
Humans
Inpatients
Mental Disorders
Motivational Interviewing
New South Wales
Patient Discharge
Patient Education as Topic
Recurrence
Research Design
Smoking
Smoking Cessation
Smoking Prevention
Time Factors
Tobacco Use Disorder
Treatment Outcome
Smoking cessation
Mental illness
Inpatient
Community
Multimodal intervention
Cardiorespiratory Medicine and Haematology
Clinical Sciences
Cardiovascular System & Hematology
General & Internal Medicine
Clinical sciences
Epidemiology
Health services and systems
Language
Abstract
BackgroundSmoking rates, and associated negative health outcomes, are disproportionately high among people with mental illness compared to the general population. Smoke-free policies within mental health hospitals can positively impact on patients' motivation and self-efficacy to address their smoking. However, without post-discharge support, preadmission smoking behaviours typically resume. This protocol describes a randomised controlled trial that aims to assess the efficacy of linking mental health inpatients to community-based smoking cessation supports upon discharge as a means of reducing smoking prevalence.Methods/designEight hundred participants with acute mental illness will be recruited into the randomised controlled trial whilst inpatients at one of four psychiatric inpatient facilities in the state of New South Wales, Australia. After completing a baseline interview, participants will be randomly allocated to receive either: 'Supported Care', a multimodal smoking cessation intervention; or 'Normal Care', consisting of existing hospital care only. The 'Supported Care' intervention will consist of a brief motivational interview and a package of self-help material for abstaining from smoking whilst in hospital, and, following discharge, 16 weeks of motivational telephone-based counselling, 12 weeks of free nicotine replacement therapy, and a referral to the Quitline. Data will be collected at 1, 6 and 12 months post-discharge via computer-assisted telephone interview. The primary outcomes are abstinence from smoking (7-day point prevalence and prolonged cessation), and secondary outcomes comprise daily cigarette consumption, nicotine dependence, quit attempts, and readiness to change smoking behaviour.DiscussionIf shown to be effective, the study will provide evidence in support of systemic changes in the provision of smoking cessation care to patients following discharge from psychiatric inpatient facilities.Trial registrationAustralian New Zealand Clinical Trials Registry ANZTCN: ACTRN12612001042831. Date registered: 28 September 2012.